Vascular access for haemodialysis is key in renal patients both due to its associated
morbidity and mortality and due to its impact on quality of life. The process, from the creation …

Abstract The National Kidney Foundation's Kidney Disease Outcomes Quality Initiative
(KDOQI) has provided evidence-based guidelines for hemodialysis vascular access since …

When the evidence of literature is weak, conflicting, or contradictory, consensus for the
parameter is reached by a minimum of 12 Standards of Practice Committee members using …

Purpose To compare lesion primary patency and restenosis rates between drug-eluting
balloon (DEB) percutaneous transluminal angioplasty (PTA) and conventional balloon PTA …

With the increasing prevalence of end-stage renal disease, there is a growing need for
hemodialysis. Arteriovenous fistulae (AVF) are the preferred type of vascular access for …

Purpose To report 1-year results of a single-center randomized controlled trial comparing
paclitaxel-coated balloon (PCB) versus high-pressure plain balloon angioplasty for the …

Rationale & Objective Previous studies have illustrated the potential superiority of drug-
coated balloons (DCBs) in maintaining patency after initial angioplasty for arteriovenous …

Purpose To investigate the potential added value of paclitaxel-coated balloon (PCB)
angioplasty to reduce fistula dysfunction related to recurrent stenoses in patients undergoing …

The number of patients in dialysis increases every year. In this review, we will evaluate the
role of percutaneous transluminal angioplasty (PTA) according to patency of arteriovenous …

Background and Objective The majority of patients with end-stage renal disease (ESRD)
requiring hemodialysis (HD) do so via an arteriovenous fistula (AVF) or graft. Both of these …